000 01529 a2200433 4500
005 20250515211211.0
264 0 _c20100729
008 201007s 0 0 eng d
022 _a1365-2141
024 7 _a10.1111/j.1365-2141.2010.08138.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMangiacavalli, Silvia
245 0 0 _aEmergent T-helper 2 profile with high interleukin-6 levels correlates with the appearance of bortezomib-induced neuropathic pain.
_h[electronic resource]
260 _bBritish journal of haematology
_cJun 2010
300 _a916-8 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Letter; Multicenter Study
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aBoronic Acids
_xadverse effects
650 0 4 _aBortezomib
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterleukin-6
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Myeloma
_xdrug therapy
650 0 4 _aNeuralgia
_xchemically induced
650 0 4 _aProspective Studies
650 0 4 _aPyrazines
_xadverse effects
650 0 4 _aTh2 Cells
_xdrug effects
700 1 _aCorso, Alessandro
700 1 _aDe Amici, Mara
700 1 _aVarettoni, Marzia
700 1 _aAlfonsi, Enrico
700 1 _aLozza, Alessandro
700 1 _aLazzarino, Mario
773 0 _tBritish journal of haematology
_gvol. 149
_gno. 6
_gp. 916-8
856 4 0 _uhttps://doi.org/10.1111/j.1365-2141.2010.08138.x
_zAvailable from publisher's website
999 _c19569425
_d19569425